Hooman Behravan, DO
Pain Medicine · San Leandro, CANPI 1255308904
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (35.3%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Lilly USA, LLC accounts for 65.1% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2019 at $6,143 and has fallen 99.4% since, to $36 in 2025.
Across 198 payments — averaging $43.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$6K
- Scilex Pharmaceuticals Inc.$1K
- AbbVie$291
- Collegium Pharmaceutical, Inc.$251
- Alkermes, Inc.$157
- Merz Pharmaceuticals, LLC$157
- plus $984 from 25 others
What the payments were for
- Consulting fees$2,58830%
- Speaking & faculty fees$3,00035%
- Food & beverage$3,04335%
- Gifts$00%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 5 | $5,616 |
| Scilex Pharmaceuticals Inc. | 100 | $1,175 |
| AbbVie(2 entities) | 15 | $291 |
| Collegium Pharmaceutical, Inc. | 15 | $251 |
| Alkermes, Inc. | 3 | $157 |
| Merz Pharmaceuticals, LLC | 9 | $157 |
| Chiesi USA, Inc. | 5 | $121 |
| Nevro Corp. | 3 | $107 |
| Pfizer | 6 | $93 |
| Abbott | 2 | $87 |
| Biodelivery Sciences International, Inc. | 6 | $83 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $74 |
| Nalu Medical, Inc. | 3 | $59 |
| Tersera Therapeutics LLC | 2 | $37 |
| Stimwave Technologies Incorporated | 3 | $31 |
| Vertos Medical, Inc. | 2 | $29 |
| Boston Scientific | 1 | $24 |
| Forte Bio-pharma LLC | 1 | $23 |
| Indivior Inc. | 1 | $22 |
| Vertex | 1 | $20 |
| Si-bone, Inc. | 1 | $19 |
| ERMI LLC | 1 | $19 |
| AstraZeneca | 1 | $19 |
| Amgen | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Neuronetics, Inc. | 1 | $15 |
| Vertiflex, Inc. | 1 | $15 |
| GRT US Holding, Inc. | 1 | $14 |
| Tenex Health Inc. | 1 | $14 |
| Novartis | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,631 in reported general payments places this provider in the 80th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 14 | $17,200 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 144 | $3,208 |
| Fentanyl | 17 | $2,313 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $974 |
| Oxycodone Hcl | 14 | $569 |
| Morphine Sulfate ErMorphine Sulfate | 30 | $514 |
| Celecoxib | 15 | $464 |
| Gabapentin | 61 | $452 |
| Pregabalin | 27 | $429 |
| Cyclobenzaprine Hcl | 19 | $223 |
| Topiramate | 19 | $195 |
| Naproxen | 15 | $123 |
| Tizanidine Hcl | 13 | $99 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in San Leandro
- Jason PopeSanta Rosa$2.1M
- Ramana NaiduLarkspur$1.4M
- Foead GeulaStudio City$1.3M
- Krishnan ChakravarthyTemecula$1.3M
- Kasra AmirdelfanWalnut Creek$783K
- Eric GrigsbyNapa$499K
- Jacqueline WeisbeinNapa$494K
- Gerald SacksSanta Monica$389K
- Samir ShethRoseville$356K
- Einar OttestadStanford$352K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.